Sustainable Biocatalytic Synthesis of (S)-β-Nitro Alcohols using a Promiscuous (R)-Selective Hydroxynitrile Lyase
Sustainable Biocatalytic Synthesis of (S)-β-Nitro Alcohols using a Promiscuous (R)-Selective Hydroxynitrile Lyase
Files
Date
2021-12
Authors
Sreenivasa Rao, D. H.
Journal Title
Journal ISSN
Volume Title
Publisher
University of Hyderabad
Abstract
A chiral β-nitroalcohol possesses two versatile, functional groups, a nitro and a hydroxyl,
attached to vicinal carbon centers of which either one or both are asymmetric. They are
essential precursors to many synthetically useful structural motifs and pharmaceuticals. The
potential to transform both the nitro and hydroxyl group in a β-nitroalcohol structure could
produce a diverse range of synthetic molecules with one or more different functional groups.
The nitro group can be altered to amine, carbonyl, nitrile, nitrile oxide, oxime, hydroxylamine,
etc.1 Chiral vicinal amino alcohols that are key building blocks of a number of β-blockers used
to cure cardiovascular diseases are synthesized by a simple reduction of the nitro group of
corresponding chiral β-nitroalcohols.2 The nitro group of a β-nitroalcohol is converted to a
carbonyl using Nef reaction to produce α-hydroxy carbonyl.3 It undergoes denitration where
the nitro group is replaced by a hydrogen.4 Similarly, the hydroxyl group can be subjected to
elimination, Ritter reaction, oxidation, acetylation, etc. Simple elimination in case of a β-
nitroalcohol produces nitro alkene.5 In Ritter reaction, the hydroxyl group reacts with a nitrile
under acidic conditions and converts it into corresponding N-(β-nitro)amide.6 The hydroxyl
group of a β-nitroalcohol can be derivatized, i.e., acetylated to produce acetylated nitroalcohol.
A few examples of different drug molecules and natural products for whom (S)-β-nitroalcohols
happened to be structural components are, chelonin A7 (antimicrobial), and (S)-tembamide8
(anti-HIV), (S)-toliprolol, (S)-moprolol9, and (S)-propranolol10, (S)-norphenylephrine11 (β-
adrenergic receptor blocking agents), (S)-sotalol12 (antiarrhythmic agents), and (S)-
miconazole13 (antifungal) (Figure 1.1, upper).